Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative study
- PMID: 34086876
- DOI: 10.1093/rheumatology/keab471
Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative study
Abstract
Objectives: Immunization is an essential component of RA care. Nevertheless, vaccine coverage in RA is suboptimal. Contextual, individual and vaccine-related factors influence vaccine acceptance. However, barriers and facilitators of vaccination in RA are not well defined. The aim of this study was to assess perspectives of RA patients and healthcare professionals (HCPs) involved in RA care of barriers and facilitators regarding influenza and pneumococcal vaccines.
Methods: Eight focus groups (four with RA patients and four with HCPs) and eight semi-structured open-ended individual interviews with vaccine-hesitant RA patients were conducted. Data were audio recorded, transcribed verbatim and imported to MAXQDA software. Analysis using the framework of vaccine hesitancy proposed by the Strategic Advisory Group of Experts on Immunization was conducted.
Results: RA patients and HCPs reported common and specific barriers and facilitators to influenza vaccination that included contextual, individual and/or group and vaccine- and/or vaccination-specific factors. A key contextual influence on vaccination was patients' perception of the media, pharmaceutical industry, authorities, scientists and the medical community at large. Among the individual-related influences, experiences with vaccination, knowledge/awareness and beliefs about health and disease prevention were considered to impact vaccine acceptance. Vaccine-related factors including concerns about vaccine side effects such as RA flares, the safety of new formulations, the mechanism of action, access to vaccines and costs associated with vaccination were identified as actionable barriers.
Conclusion: Acknowledging RA patients' perceived barriers to influenza and pneumococcal vaccination and implementing specific strategies to address them might increase vaccination coverage in this population.
Keywords: RA; influenza vaccine; pneumococcal vaccine; vaccine; vaccine hesitancy.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.PLoS One. 2022 Sep 9;17(9):e0267769. doi: 10.1371/journal.pone.0267769. eCollection 2022. PLoS One. 2022. PMID: 36084032 Free PMC article.
-
Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review.Clin Rheumatol. 2021 Feb;40(2):477-489. doi: 10.1007/s10067-020-05059-7. Epub 2020 Jul 3. Clin Rheumatol. 2021. PMID: 32621081
-
Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).Scand J Rheumatol. 2017 Nov;46(6):446-453. doi: 10.1080/03009742.2016.1242774. Epub 2017 Feb 1. Scand J Rheumatol. 2017. PMID: 28145151
-
Factors influencing influenza vaccine uptake among adults in Johannesburg, South Africa: A qualitative study.Vaccine. 2025 May 31;57:127133. doi: 10.1016/j.vaccine.2025.127133. Epub 2025 May 7. Vaccine. 2025. PMID: 40339181
-
A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.J Rheumatol. 2018 Jun;45(6):733-744. doi: 10.3899/jrheum.170710. Epub 2018 Mar 15. J Rheumatol. 2018. PMID: 29545454
Cited by
-
Vaccination Rates and Influencing Factors in Patients with Axial Spondyloarthritis and Immunosuppressive Treatment-A Survey-Based Cross-Sectional Study.Vaccines (Basel). 2024 Jul 9;12(7):756. doi: 10.3390/vaccines12070756. Vaccines (Basel). 2024. PMID: 39066394 Free PMC article.
-
Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.PLoS One. 2022 Sep 9;17(9):e0267769. doi: 10.1371/journal.pone.0267769. eCollection 2022. PLoS One. 2022. PMID: 36084032 Free PMC article.
-
Knowledge and practices of vaccination for children with rheumatic diseases: A single-center study in China.Hum Vaccin Immunother. 2023 Dec 31;19(1):2215108. doi: 10.1080/21645515.2023.2215108. Epub 2023 May 21. Hum Vaccin Immunother. 2023. PMID: 37211623 Free PMC article.
-
Patients with immune mediated inflammatory diseases are insufficiently protected against vaccine-preventable infections.Infection. 2025 Feb;53(1):317-327. doi: 10.1007/s15010-024-02373-z. Epub 2024 Aug 22. Infection. 2025. PMID: 39172350 Free PMC article.
-
Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America.Mult Scler J Exp Transl Clin. 2021 Nov 29;7(4):20552173211061543. doi: 10.1177/20552173211061543. eCollection 2021 Oct. Mult Scler J Exp Transl Clin. 2021. PMID: 34868630 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical